Evidence map›Paper›PMID 41466306›Full record

ArticleAlzheimer's research & therapy2025

Thirty-seven-year trends in the prevalence, incidence, and prognosis of dementia in a Japanese community: the Hisayama study.

Tomoyuki Ohara, Toshifumi Minohara, Taro Nakazawa, Emi Oishi, Yoshihiko Furuta, Satoko Sakata, Takanori Honda, Mao Shibata, Jun Hata, Tomohiro Nakao and 1 more

Abstract read
In one paragraph

Article in Alzheimer's research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tomoyuki OharaDepartment of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. ohara.tomoyuki.287@m.kyushu-u.ac.jp.
Toshifumi MinoharaDepartment of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Taro NakazawaDepartment of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Emi OishiDepartment of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yoshihiko FurutaDepartment of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Satoko SakataDepartment of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Takanori HondaDepartment of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Mao ShibataDepartment of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Jun HataCenter for Cohort Studies, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Tomohiro NakaoDepartment of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Toshiharu NinomiyaDepartment of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Funding

Japan Agency for Medical Research and Development JP25dk0207053, JP25km0405209, JP25tm0524003, JP25he2202021 and JP25dk0307136Japan Science and Technology Agency JPMJPF2210Ministry of Education, Culture, Sports, Science and Technology JP22K07421, JP23K09692, JP23K09717, JP23K16330, JP23K06787, JP23K09060, and JP25K13589Ministry of Health, Labour and Welfare JPMH23FA1006, JPMH24GB1002 and JPMH24FA1005
6 · The paper itself

Abstract

backgroundFew population-based studies have investigated how the prevalence, incidence, and survival rate of dementia have changed since the 2010s in Asian communities. We investigated this issue using 37 years of epidemiological data in a Japanese community.

methodsSeven cross-sectional surveys of dementia were conducted among residents aged ≥ 65 years in a Japanese community in 1985, 1992, 1998, 2005, 2012, 2017, and 2022. We also established three cohorts in the residents aged ≥ 65 years without dementia in 1988 (n = 803), 2002 (n = 1,231), and 2012 (n = 1,519), each of which was followed for 10 years. Trends in the prevalence of dementia were tested using a logistic regression model. The age- and sex-adjusted incidence of dementia and survival rate after dementia onset were compared across cohorts using a Cox proportional hazards model.

resultsThe crude prevalence of dementia significantly increased from 1985 to 2012 (6.7% in 1985, 5.7% in 1992, 7.1% in 1998, 12.5% in 2005, and 17.9% in 2012, p for trend < 0.01), but then decreased significantly from 2012 to 2022 (15.8% in 2017 and 12.1% in 2022; p for trend < 0.01). A similar trend was observed after adjusting for age and sex. Moreover, the age- and sex-adjusted incidence of dementia increased significantly from the 1988 to the 2002 cohort (adjusted hazard ratio [aHR] 1.68, 95% confidence intervals [CI] = 1.38-2.06), but decreased significantly from the 2002 to the 2012 cohort (aHR = 0.60, 95% CI = 0.51-0.70). The age- and sex-adjusted 5-year survival rate after dementia onset increased significantly from the 1988 to the 2002 cohort (47.3% to 65.2%; p < 0.01), while no significant change was observed from the 2002 to the 2012 cohort (65.2% to 58.9%; p = 0.42).

conclusionsDecreasing trends in the prevalence and incidence of dementia were observed since 2012 in a Japanese community. The decline in the incidence of dementia may be due to the prevention and improved management of lifestyle-related diseases, such as hypertension and diabetes, as well as increased awareness and promotion of healthy lifestyle behaviors.

Indexed as

DementiaAgedAged, 80 and overCohort StudiesCross-Sectional StudiesEast Asian PeopleFemaleHumansIncidenceJapanMalePrevalencePrognosisSurvival RateDementiaIncidenceMortalityPrevalenceSurvival rate

Identifiers

PMID41466306
PMCPMC12751825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.